ChemoMetec Stock
ChemoMetec Stock price
Key metrics
Is ChemoMetec a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.
ChemoMetec Stock Analysis
Analyst Opinions
11 Analysts have issued a ChemoMetec forecast:
Analyst Opinions
11 Analysts have issued a ChemoMetec forecast:
Financial data from ChemoMetec
| Dec '24 |
+/-
%
|
||
| Revenue | 460 460 |
14%
14%
|
|
| Gross Profit | 368 368 |
16%
16%
|
|
| EBITDA | 228 228 |
15%
15%
|
EBIT (Operating Income) EBIT | 210 210 |
17%
17%
|
| Net Profit | 169 169 |
18%
18%
|
|
In millions DKK.
Don't miss a Thing! We will send you all news about ChemoMetec directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for fluid cell count and analysis. It operates through the following segments: Instruments, Consumer Goods, Service, and Others. The Instruments segment sells NucleoCounter NC-100, NC-200, NC250, and NC-3000. The Consumer Goods segment offers disposable cartridges, disposable analysis chambers, reagents, and test kits. The Service segment provides service packages and its corresponding guarantees. The Others segment offers measuring modules and accessories. The company was founded by Hans Martin Glensbjerg in 1977 and is headquartered in Allerod, Denmark.
| Head office | Denmark |
| CEO | Mr. Behrens |
| Employees | 184 |
| Founded | 1997 |
| Website | chemometec.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
